Sign inGet started

Tardio Jason

Insider CIK 1794698 · IMUX President and COO · OVID Chief Operating Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IMUX IMMUNIC, INC. A Award deriv2026-06-292026-06-29253,000— $0253,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-07-162025-07-18660,000— $0660,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-07-162025-07-18330,000— $0330,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-07-162025-07-18660,000— $0660,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-07-162025-07-18330,000— $0330,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-07-162025-07-18330,000— $0330,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-06-052025-06-09595,000— $0595,000SEC↗
IMUX IMMUNIC, INC. A Award deriv2025-06-052025-06-20598,500— $0598,500SEC↗
IMUX IMMUNIC, INC. P Buy2025-06-052025-06-0912,512$0.79 $9.9K12,512SEC↗
IMUX IMMUNIC, INC. P Buy2025-06-052025-06-2012,512$0.79 $9.9K12,512SEC↗
IMUX IMMUNIC, INC. A Award deriv2024-12-042024-12-06157,500— $0157,500SEC↗
IMUX IMMUNIC, INC. A Award deriv2024-07-122024-07-12500,000— $0500,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2024-02-222024-02-26168,750— $0168,750SEC↗
OVID Ovid Therapeutics Inc. A Award2024-02-222024-02-2628,125— $028,125SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2023-02-232023-02-27175,000— $0175,000SEC↗
OVID Ovid Therapeutics Inc. S Sale2022-09-122022-09-1417,344$2.15 $37.3K0SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2022-04-082022-04-1287,498— $087,498SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2022-04-082022-04-1210,000— $010,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2022-02-032022-02-04175,000— $0175,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2021-07-012021-07-0150,000— $050,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2021-02-052021-02-0875,000— $075,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2020-12-172020-12-21175,000— $0175,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2020-11-252021-04-2944,000— $044,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2020-06-192020-06-2350,000— $050,000SEC↗
OVID Ovid Therapeutics Inc. A Award deriv2019-11-182019-11-21125,000— $0125,000SEC↗